Edition:
United States

AzurRx BioPharma Inc (AZRX.OQ)

AZRX.OQ on NASDAQ Stock Exchange Capital Market

2.33USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$2.33
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,129
52-wk High
$5.25
52-wk Low
$2.21

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -0.216
Mar '18 0.00 -0.292
FY 2017 Dec '17 0.00 -0.215
Sep '17 0.00 -0.279
Jun '17 0.00 -0.265
Mar '17 0.00 -0.292
FY 2016 Dec '16 0.00 -0.608
Sep '16 0.00 -0.530
Jun '16 0.00 -0.392
Mar '16 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 1 0.00 0.00 0.00 --
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Year Ending Dec-18 1 0.00 0.00 0.00 0.00
Year Ending Dec-19 1 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Sep-18 1 -0.21 -0.21 -0.21 -0.17
Quarter Ending Dec-18 1 -0.21 -0.21 -0.21 -0.17
Year Ending Dec-18 1 -0.91 -0.91 -0.91 -0.67
Year Ending Dec-19 1 -0.78 -0.78 -0.78 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 28.29 30.45
P/E High - Last 5 Yrs. -- 42.14 47.36
P/E Low - Last 5 Yrs. -- 23.56 24.74
Beta -- 0.86 0.84
Price to Sales (TTM) -- 3.55 5.98
Price to Book (MRQ) 5.13 3.30 3.69
Price to Tangible Book (MRQ) 8.30 4.76 5.63
Price to Cash Flow (TTM) -- 19.42 20.97
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.93 1.78
Dividend Yield - 5 Year Avg -- 1.54 1.46
Dividend 5 Year Growth Rate -- -8.80 -5.93
Payout Ratio(TTM) -- 49.41 46.55

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.58 7.18
Sales (TTM) vs TTM 1 Yr. Ago -- 10.86 12.05
Sales - 5 Yr. Growth Rate -- 6.99 7.61
EPS (MRQ) vs Qtr. 1 Yr. Ago 18.53 18.83 23.85
EPS (TTM) vs TTM 1 Yr. Ago 40.94 -- --
EPS - 5 Yr. Growth Rate -- 6.40 7.52
Capital Spending - 5 Yr. Growth Rate -- 7.47 8.06

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.53 2.50
Current Ratio (MRQ) 3.31 3.58 3.53
LT Debt to Equity (MRQ) 0.00 8.93 11.27
Total Debt to Equity (MRQ) 3.70 11.33 14.23
Interest Coverage (TTM) -1.65 37.13 31.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.69 55.23
Gross Margin - 5 Yr. Avg. -- 53.35 53.33
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.82 15.82
Operating Margin (TTM) -- 14.40 3.86
Operating Margin - 5 Yr. Avg. -- 14.40 10.95
Pre-Tax Margin (TTM) -- 14.69 4.16
Pre-Tax Margin - 5 Yr. Avg. -- 14.64 11.12
Net Profit Margin (TTM) -- 11.33 0.98
Net Profit Margin - 5 Yr. Avg. -- 10.95 7.47
Effective Tax Rate (TTM) -- 20.38 20.36
Effective Tax Rate - 5 Yr. Avg. -- 23.80 24.15

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 825,982,481 718,909,906
Net Income/Employee (TTM) -- 96,230,889 83,624,743
Receivable Turnover (TTM) -- 5.39 5.38
Inventory Turnover (TTM) -- 2.45 3.51
Asset Turnover (TTM) 0.00 0.85 0.83

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -122.49 10.33 10.04
Return on Assets - 5 Yr. Avg. -- 11.42 10.94
Return on Investment (TTM) -163.80 12.92 12.63
Return on Investment - 5 Yr. Avg. -- 14.82 14.14
Return on Equity (TTM) -204.64 14.94 14.82
Return on Equity - 5 Yr. Avg. -- 16.10 15.50
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 53.46 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AzurRx BioPharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.65%
# of Holders: 21
Total Shares Held: 3,153,430
3 Mo. Net Change: 2,258,777
# New Positions: 8
# Closed Positions: 2
# Increased Positions: 15
# Reduced Positions: 2
# Net Buyers: 13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.